Alejandro Yeste-Vázquez

Alejandro Yeste-Vázquez

Auto-generated profile, based on publicly available information

Alejandro Yeste-Vázquez

Department of Chemistry and Pharmaceutical Sciences, Vrije Universiteit Amsterdam, Amsterdam, Netherlands

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 December 2023 in Nature Synthesis
Verified
Journal Article
Closed access
PDF file
MBMiguel Bernús
Miguel Bernús
DMDaniele Mazzarella
Daniele Mazzarella
JSJelena Stanić
Jelena Stanić
ZZZiran Zhai
Ziran Zhai
AYAlejandro Yeste-Vázquez
Alejandro Yeste-Vázquez
TNTimothy Noël
Timothy Noël

31 January 2024 in Nature Synthesis
Verified
Journal Article
Open access
PDF file
MBMiguel Bernús
Miguel Bernús
DMDaniele Mazzarella
Daniele Mazzarella
JSJelena Stanić
Jelena Stanić
ZZZiran Zhai
Ziran Zhai
AYAlejandro Yeste-Vázquez
Alejandro Yeste-Vázquez
TNTimothy Noël
Timothy Noël

8 September 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
GMGanesh babu MANOHARAN
Ganesh babu MANOHARAN
CSCandy Laura Steffen
Candy Laura Steffen
KPKarolina Pavic
Karolina Pavic
AYAlejandro Yeste-Vázquez
Alejandro Yeste-Vázquez
MKMatias Knuuttila
Matias Knuuttila
Daniel AbankwaDaniel Abankwa
Daniel Abankwa
The Ras-MAPK pathway is critical to regulate cell proliferation and differentiation. Its dysregulation is implicated in the onset and progression of numerous types of cancers. To be active, Ras proteins are membrane anchored and organized into nanoclusters, which realize high-fidelity signal transmission across the plasma membrane. Nanoclusters therefore represent potential drug targets. However, targetable protein components of signalling nanoclusters are poorly established. We previously proposed that the nanocluster scaffold galectin-1 (Gal1) enhances H-Ras nanoclustering by stabilizing stacked dimers of H-Ras and Raf via a direct interaction of dimeric Gal1 with the Ras binding domain (RBD) in particular of B-Raf. Here, we provide further supportive evidence for this model. We establish that the B-Raf preference emerges from divergent regions of the Raf RBDs that were proposed to interact with Gal1. We then identify the L5UR peptide, which disrupts this interaction by binding with low micromolar affinity to the B-Raf-RBD. Its 23-mer core fragment is thus sufficient to interfere with Gal1-enhanced H-Ras nanocluster, reduce MAPK-output and cell viability in HRAS -mutant cancer cell lines. Our data therefore suggest that the interface between Gal1 and the RBD of B-Raf can be targeted to disrupt Gal1-enhanced H-Ras nanoclustering. Collectively, our results support that Raf-proteins are integral components of active Ras nanoclusters.

10 September 2026 in ChemistryEurope
Verified
Journal Article
Open access
MMMichael H. N. Meulendijks
Michael H. N. Meulendijks
YLYun Li
Yun Li
FSFrederik J. Steiner
Frederik J. Steiner
RKRasmus Klintrot
Rasmus Klintrot
CSClemens Schulte
Clemens Schulte
TGTom N Grossmann
Tom N Grossmann
Peptide‐based inhibitors are promising tools to target challenging protein interfaces, yet improving their affinity and drug‐like properties is still a major hurdle. This holds particularly true for β ‐sheet motifs with only limited strategies available to robustly stabilize their conformation. Previously, we reported linear β ‐hairpin peptide l 12 with micromolar affinity for β ‐catenin, a central effector of aberrant Wnt signaling in cancer. Here, we show that a single N4V substitution markedly enhances binding, despite not directly contacting the protein surface as evidenced by obtained X‐ray structures and molecular dynamics simulations. Notably, the substitution combines additively with head‐to‐tail cyclization yielding a peptide with strongly increased affinity. This mechanistic study presents structural and computational analyses revealing that the affinity improvements arise from solution‐state preorganization and β ‐hairpin stabilization mediated by an altered intramolecular hydrogen bond network. Our findings highlight the critical role of conformational preorganization in peptide‐protein recognition, demonstrating that optimizing solution‐state properties can unlock substantial affinity gains that are not obvious from crystal structures alone.